154 related articles for article (PubMed ID: 29678569)
1. PBX1 promotes the cell proliferation via JAK2/STAT3 signaling in clear cell renal carcinoma.
Wei X; Yu L; Li Y
Biochem Biophys Res Commun; 2018 Jun; 500(3):650-657. PubMed ID: 29678569
[TBL] [Abstract][Full Text] [Related]
2. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
3. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
[TBL] [Abstract][Full Text] [Related]
4. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
[TBL] [Abstract][Full Text] [Related]
5. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
[TBL] [Abstract][Full Text] [Related]
6. Salidroside reduces renal cell carcinoma proliferation by inhibiting JAK2/STAT3 signaling.
Lv C; Huang Y; Liu ZX; Yu D; Bai ZM
Cancer Biomark; 2016 Jun; 17(1):41-7. PubMed ID: 27314291
[TBL] [Abstract][Full Text] [Related]
7. PBX1 Increases the Radiosensitivity of Oesophageal Squamous Cancer by Targeting of STAT3.
Yu D; Ma Y; Feng C; Ma Z; Guo J; Chen H; He T; Guo J; Sun X; Qin Q; Sun X; Ma J
Pathol Oncol Res; 2020 Oct; 26(4):2161-2168. PubMed ID: 32170580
[TBL] [Abstract][Full Text] [Related]
8. Nobiletin inhibits viability of human renal carcinoma cells via the JAK2/STAT3 and PI3K/Akt pathway.
Xu Z; Wu D; Fu D; Tang C; Ge J; Zhang Z; Zhou W
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):199-203. PubMed ID: 33040836
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene.
Zhu J; Zhu DQ; Zhang Y; Liu QM; Wang PC; Li HZ; Ma X; Zhang X
J Cell Physiol; 2019 Mar; 234(3):2581-2592. PubMed ID: 30229899
[TBL] [Abstract][Full Text] [Related]
10. [Silencing PBX1 expression induces apoptosis and ROS production of lung cancer cells].
Yao XP; Peng HX; Wu JR
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):843-848. PubMed ID: 33113625
[No Abstract] [Full Text] [Related]
11. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
[TBL] [Abstract][Full Text] [Related]
12. miRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells.
Zhou W; Bi X; Gao G; Sun L
Biomed Pharmacother; 2016 Dec; 84():722-729. PubMed ID: 27710896
[TBL] [Abstract][Full Text] [Related]
13. Eriocalyxin B blocks human SW1116 colon cancer cell proliferation, migration, invasion, cell cycle progression and angiogenesis via the JAK2/STAT3 signaling pathway.
Lu YM; Chen W; Zhu JS; Chen WX; Chen NW
Mol Med Rep; 2016 Mar; 13(3):2235-40. PubMed ID: 26795301
[TBL] [Abstract][Full Text] [Related]
14. Anthraquinone derivative C10 inhibits proliferation and cell cycle progression in colon cancer cells via the Jak2/Stat3 signaling pathway.
Li Y; Guo F; Chen T; Zhang L; Qin Y
Toxicol Appl Pharmacol; 2021 May; 418():115481. PubMed ID: 33722666
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model.
Shanmugam MK; Rajendran P; Li F; Kim C; Sikka S; Siveen KS; Kumar AP; Ahn KS; Sethi G
Mol Carcinog; 2015 Oct; 54(10):971-85. PubMed ID: 24797723
[TBL] [Abstract][Full Text] [Related]
16. GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation.
Wu S; Fu J; Dong Y; Yi Q; Lu D; Wang W; Qi Y; Yu R; Zhou X
J Neurooncol; 2018 Sep; 139(2):269-279. PubMed ID: 29713848
[TBL] [Abstract][Full Text] [Related]
17. Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma.
Li S; Priceman SJ; Xin H; Zhang W; Deng J; Liu Y; Huang J; Zhu W; Chen M; Hu W; Deng X; Zhang J; Yu H; He G
PLoS One; 2013; 8(12):e81657. PubMed ID: 24324713
[TBL] [Abstract][Full Text] [Related]
18. DDX5 Silencing Suppresses the Migration of Basal cell Carcinoma Cells by Downregulating JAK2/STAT3 Pathway.
Quan Z; Zhang BB; Yin F; Du J; Zhi YT; Xu J; Song N
Technol Cancer Res Treat; 2019; 18():1533033819892258. PubMed ID: 31870221
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
20. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
Fu LX; Lian QW; Pan JD; Xu ZL; Zhou TM; Ye B
J Biol Regul Homeost Agents; 2017; 31(1):51-58. PubMed ID: 28337870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]